Assoc. Prof. Dr. CEVPER ERSÖZ

Urology

MEDİPOL Acıbadem District Hospital

Make an Appointment

Birthplace

BURSA

Languages

İNGİLİZCE

Medical Areas of Interest

Kidney Cancer
Prostate Cancer
Bladder Cancer
Testicular Cancer
Benign Prostatic Hyperplasia (BPH)
Kidney and Ureteral Stones
Infertility
Voiding Disorders
Ureteral Strictures
General Urological Diseases

Highlights

Assoc. Prof. Dr. Cevper Ersöz was born in Bursa in 1981. He completed his pre-university education in Balıkesir. He graduated from Istanbul Faculty of Medicine in 2006 and completed his residency training in Urology at Bezmialem Vakıf University Faculty of Medicine in 2012, qualifying as a Urology Specialist.

During his residency training in 2011, he spent time at the Department of Urology at the University of Michigan in the USA, where he gained clinical experience in advanced laparoscopic surgery, robotic surgery, and endourology.

After completing his mandatory service as a Urology Specialist at Şırnak İdil State Hospital in 2014, he worked as a Urology Specialist at Giresun Dr. A. İlhan Özdemir State Hospital from 2014 to 2015. In 2015, he joined the Department of Urology at Bezmialem Vakıf University as a faculty member. In 2021, he earned the title of FEBU (Fellow of the European Board of Urology) after successfully passing the European Board of Urology examination. He was appointed Associate Professor at the same institution in 2023 and continued his academic and clinical activities there until 2024.

He currently continues his clinical and academic practice at Medipol Acıbadem District Hospital and Istanbul Medipol University. In 2025, he visited Westmoreland Street Hospital (UCL, London) as an observer in advanced robotic surgery for urologic oncology.

Throughout his career, from his residency training through his post-specialization practice, he has focused particularly on urologic oncology and endoscopic surgery. He has performed more than 10,000 procedures using laparoscopic, robotic, and endoscopic surgical techniques. He has extensive clinical and surgical experience in the treatment of prostate cancer, including robotic and open surgery; kidney and ureteral tumors, using robotic, laparoscopic, and open surgical techniques; and bladder cancer, ranging from endoscopic procedures for early-stage disease to radical surgery for advanced disease. He also has experience in the treatment of testicular cancer at all stages. His areas of interest additionally include the management of prostate diseases and endourological procedures, including surgery for kidney stones.

Assoc. Prof. Dr. Cevper Ersöz has authored more than 40 scientific articles and over 10 book chapters and reviews published in national and international peer-reviewed journals. His publications have received more than 1,600 citations in the international scientific literature.

Assoc. Prof. Dr. Cevper Ersöz continues his clinical, academic, and educational activities at both national and international levels, with a consistent focus on achieving successful patient outcomes and ensuring patient satisfaction.

Experiences

2015 - 2024

Bezmialem Vakıf Üniversitesi, Üroloji Anabilim Dalı

2014 - 2015

Giresun Dr.A.İlhan Özdemir Devlet Hastanesi, Giresun

2012 - 2014

İdil Devlet Hastanesi, İdil, Şırnak

2011 - 2011

University of Michigan, Department of Urology, Ann Arbor, MI, USA

2010 - 2012

Bezmialem Üniversitesi, Üroloji Anabilim Dalı

2007 - 2010

Bezmialem Valide Sultan Vakıf Gureba Eğitim ve Araştırma Hastanesi, Üroloji Kliniği

2006 - 2007

İstanbul Üniversitei İstanbul Tıp Fakültesi, Anatomi Anabilim Dalı

Educations

2012

İstanbul Bezmialem Vakıf Üniversitesi, Üroloji

2006

İstanbul Üniversitesi, Tıp Fakültesi

Publications

7.1. Uluslar arası hakemli dergilerde yayınlanan makaleler

7.1.1. Curcumin prevents oxidative renal damage induced by acetaminophen in rats. Cekmen M, Ilbey YO, Ozbek E, Simsek A, Somay A, Ersoz C. Food Chem Toxicol; 47(7):1480-4 (2009).

7.1.2. Impact of percutaneous renal access technique on outcomes of percutaneous nephrolithotomy.Tepeler A, Armağan A, Akman T, Polat EC, Ersöz C, Topaktaş R, Erdem MR, Onol SY. J Endourol; 26(7):828-33 (2012).

7.1.3. Re: Xu Y: Doppler Ultrasound-guided Percutaneous Nephrolithotomy With Two-step Tract Dilation for Management of Complex Renal Stones. Tepeler A, Akman T, Ersoz C, Armagan A. Urology; 80(3):745-6 (2012).

7.1.4. The role of microperc in the treatment of symptomatic lower pole renal calculi.Tepeler A, Armagan A, Sancaktutar AA, Silay MS, Penbegul N, Akman T, Hatipoglu NK, Ersoz C, Erdem MR, Akcay M. J Endourol; 27(1):13-8 (2013).

7.1.5. Is the percutaneous nephrolithotomy procedure complicated in patients with anterior caliceal stones? Tepeler A, Bozkurt OF, Resorlu B, Silay MS, Ozyuvali E, Ersoz C, Akcay M, Akman T, Armagan A, Unsal A. Urol Int; 90(4):389-93 (2013).

7.1.6. Circumcision during the phallic period: does it affect the psychosexual functions in adulthood? Armagan A, Silay MS, Karatag T, Akman T, Tepeler A, Ersoz C, Akcay M. Andrologia Feb 5. Doi 10.1111/and.12071 (2013).

7.1.7. Micropercutaneous nephrolithotomy in the treatment of moderate-size renal calculi.

Armagan A, Tepeler A, Silay MS, Ersoz C, Akcay M, Akman T, Erdem MR, Onol SY.

J Endourol; 27(2):177-81 (2013).

7.1.8. Comparison of flexible and rigid cystoscopy-assisted ureteral catheter insertion before percutaneous nephrolithotomy: a prospective randomized trial. Tepeler A, Silay MS, Akman T, Akcay M, Ersoz C, Kardas S, Erdem MR, Armagan A, Onol SY. J Endourol; 27(6): 722-6 (2013).

7.1.9. Comparison of intrarenal pelvic pressure during micro-percutaneous nephrolithotomy and conventional percutaneous nephrolithotomy.Tepeler A, Akman T, Silay MS, Akcay M, Ersoz C, Kalkan S, Armagan A, Sarica K. Urolithiasis; Feb 13. (2014).

7.1.10. Our experience in chordee without hypospadias: results of 102 cases. Polat EC, Erdem MR, Topaktas R, Ersoz C, Onol SY. Urol J; Sep 6;11(4):1783-7 (2014)

7.1.11. Iatrogenic Rectal Injury During Radical Prostatectomy: Is Colostomy Inevitable End? Topaktaş R, Erdem MR, Polat EC, Ersöz C, Önol ŞY. J Clin Anal Med ; DOI: 10.4328/JCAM.3419.(2015)

7.1.12. A Modified Antegrade Stenting Technique for Laparoscopic Pyeloplasty in Infants and Children. Kalkan S, Ersöz C, Armagan A, Taşçı Aİ, Silay MS. Urol Int. 2016;96(2):183-7. (2016)

7.1.13. Comparison of Scoring Systems in Predicting Success of Percutaneous Nephrolithotomy. Akçay M, Tosun M, Gevher F, Kalkan S, Ersöz C, Kayalı Y, Tepeler A. Balkan Med J. Jan 1;36(1):32-36. (2019)

7.1.14. Mesh related vesico-peritoneal fistula presenting with urinary ascites: A case report. Ilktac A, Ersoz C, Dogan B, Kalkan S. Urol Case Rep. Dec 4;23:39-40.(2018)

7.1.15. The relationship of neutrophil to lymphocyte ratio with testicular cancer. Ilktac A, Dogan B, Ersoz C, Akcay M, Akbulut H. Int Braz J Urol. Jan-Feb;46(1):101-107 (2020)

7.1.16. Efficacy of varicocelectomy in primary infertile patients with isolated teratozoospermia. A retrospective analysis. Ilktac A, Hamidli S, Ersoz C, Dogan B, Akcay M. Andrologia. 2020 Dec;52(11):e13875

7.1.17. Association of intrinsic sphincter deficiency with urine flow acceleration measurement. Karasu AFG, Aydın S, Kalkan S, Ersoz C. Low Urin Tract Symptoms. 2021 Jan;13(1):154-159.

7.1.18. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? Demir T, Aliyev A, Beşiroğlu M, Araz M, Köstek O, Sakin A, Shbair ATM, Çoban G, Ersöz C, Şeker M, Türk HM. Curr Probl Cancer. 2021 Feb;45(1):100619

7.1.19. The optimal settings of holmium YAG laser in treatment of pediatric urolithiasis. Ersoz C, Ilktac A, Dogan B, Kalkan S, Danacioglu YO, Silay MS. Lasers Med Sci. 2021 Jan 21. doi: 10.1007/s10103-021-03251-y. Online ahead of print.

7.1.20. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. COVIDSurg Collaborative; GlobalSurg Collaborative. Anaesthesia. 2021 Jun;76(6):748-758.

7.1.21. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort. Danacioglu YO, Keser F, Ersoz C, Polat S, Avci AE, Kalkan S, Silay MS. J Pediatr Urol. 2021 Feb 23:S1477-5131(21)00102-9.

7.1.22. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. COVIDSurg Collaborative, GlobalSurg Collaborative. Br J Surg. 2021 Mar 24:znab101. doi: 10.1093/bjs/znab101. Online ahead of print.

7.1.23. Primitive Neuroectodermal Tumor of the Testis. Demir T, Aliyev A, Seker M, Ersoz C, Coban G, Turk HM. J Coll Physicians Surg Pak. 2021 Nov;31(11):1362-1365. doi: 10.29271/jcpsp.2021.11.1362. PMID: 34689500.

7.1.24. Ersoz C, İlktac A, Kalkan S, et al. Systematic versus cognitive targeted biopsy: evaluation of parameters related to clinically significant prostate cancer and comparison of detection rates. New J Urol. 2022;17(3):187-195. https://doi.org/10.33719/yud.2022;17-3-1143471

7.1.25. Kayalı Y, Balbay MD, İlktaç A, Ersöz C, Toprak H, Tarım K, Eden AB, Akçay M, Doğan B. PSA change after antibiotic treatment should not affect decision making on performing a prostate biopsy. Turk J Med Sci. 2023 Feb;53(1):183-192. doi: 10.55730/1300-0144.5571. Epub 2023 Feb 22. PMID: 36945961; PMCID: PMC10388076.

7.1.26. Çoban G, Yıldız P, Şahin N, Ersöz C, Toprak A, Ünver N, Elagöz Ş. CD47 expression in urothelial carcinoma and its correlation with histopathological findings. Indian J Cancer. 2023 Oct 1;60(4):458-463. doi: 10.4103/ijc.ijc_644_21. Epub 2023 Nov 30. PMID: 38078465.

7.1.27. Ilktac A, Dogan B, Ersoz C, Coban G, Kalkan S. Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass. J Kidney Cancer VHL. 2023 Dec 21;10(4):20-27. doi: 10.15586/jkcvhl.v10i4.287. PMID: 38145031; PMCID: PMC10748823.

7.1.28. Beyaztas H, Ersoz C, Ozkan BN, Olgun I, Polat HS, Dastan AI, Cetinkaya E, Guler EM. The role of oxidative stress and inflammation biomarkers in pre- and postoperative monitoring of prostate cancer patients. Free Radic Res. 2024 Feb;58(2):98-106. doi: 10.1080/10715762.2024.2320381. Epub 2024 Feb 23. PMID: 38373238.